The regional cerebral metabolic rate for glucose was measured in normal and portacaval shunted rats and the effects of unilateral carotid infusions of "threshold" amounts of ammonia were assessed. 8 wk after shunting the glucose metabolic rate was increased in all 20 brain regions sampled. Effects on subcortical and phylogenetically older regions of the brain were most pronounced with a 74% increase observed in the reticular formation at the collicular level. Increases in the cerebral cortex ranged from 12 to 18%. Unilateral infusions of ammonia did not affect behavior but altered the electroencephalogram and selectively increased the glucose metabolic rate in the thalamus, hypothalamus, and substantia nigra in half ofthe animals, a pattern similar to that seen after a portacaval shunt, suggesting hyperammonemia as the cause of postshunt increases in glucose metabolism. Visual inspection of autoradiograms, computed correlation coefficients relating interregional metabolism, and principal component analysis suggest that normal cerebral metabolic and functional interrelationships are altered by shunting. Ammonia stimulation of the hypothalamic satiety centers may suppress appetite and lead to cachexia. Reductions in the ammonia detoxification capacity of skeletal muscle may increase the probability of developing future episodes of hyperammonemia, perpetuating the process. Direct effects of ammonia on specific brain centers such as the dorsomedial hypothalamus and reticular activating system may combine with global disruptions of cerebral metabolic-functional relationships to produce the protean manifestations of portal-systemic encephalopathy.
Introduction
Hyperammonemia is strongly implicated in the pathogenesis of hepatic or portal-systemic encephalopathy (1) (2) (3) (4) (5) (6) (7) (8) . In humans, this disorder is characterized by an altered level ofconsciousness, impaired cognitive functions, occasional movement disorders, abnormal muscle tone, hyperactive deep tendon reflexes, and an extensor plantar sign, due to corticospinal tract dysfunction. Hyperammonemia develops as ammonia-rich hepatic portal blood enters the systemic circulation via shunts, without passing through the liver where it is normally detoxified. Ammonia dif-fuses across the blood-brain barrier with blood-brain pH gradients (9) and regional variations in the permeability-surface area products of the barrier to ammonia (10) modulating ammonia uptake. Hyperammonemia produces a variety of neurochemical and physiological abnormalities including elevation of brain ammonia and glutamine levels, decreases in glutamate (3) , and a reduction in ATP levels in the reticular formation at the level of the inferior colliculus (5) . Neuropathological changes are confined to astrocytes, giving them characteristics of metabolically hyperactive cells (6) . Chronic shunt-induced hyperammonemia leads to the development of hypersensitivity to exogenous ammonia, as suggested by the clinical observations of Walker and Schenker (7) and blood flow and metabolic data from rats with portacaval shunts reported by Gjedde et al. (2) .
Because of the central importance of glucose metabolism in cerebral energy production, strong links between regional cerebral glucose metabolism and brain function, and confficts in the literature concerning the effects of ammonia and portacaval shunting on cerebral metabolism, we measured the cerebral glucose metabolic response to portacaval shunt construction in the rat, evaluated the effect ofselective "threshold" infusions ofammonia, administered via the carotid artery, and assessed the effect of portacaval shunts on metabolic interrelationships within the brain-its "metabolic anatomy." We confirmed the observations ofCruz and Duffy (8) , who reported that most cerebral structures increased their rate of glucose metabolism 8 wk after shunting.
We observed the largest increase in the reticular formation at the level of the colliculi, the portion of the brain implicated in the maintenance of consciousness. Although there were no discernible gross behavioral effects of threshold intracarotid infusions of ammonia, the cerebral metabolic rate for glucose was increased in a pattern similar to the increases observed after portacaval shunting in nearly half of the infused animals, suggesting that hyperammonemia is responsible for the increases observed after shunting. Finally, we used multivariate statistical techniques to evaluate metabolic interrelationships in the brain and concluded that shunting alters fundamental patterns of cerebral metabolism and presumably functional interrelationships. A preliminary report of these studies has been published (1 1).
Methods
Animal preparation. Male Wistar rats, 250-300 g, were used. End-toside portacaval shunts were constructed by the method ofLee and Fisher (12) . 8 wk postoperatively, and after an overnight fast, the animals were anesthetized with ether, paralyzed with curare, and ventilated via a tracheostomy with 70% N20 and 30% 2 SO that normal blood gas values could be maintained in all animals and possible effects of ammonia on ventilatory control could be avoided. Catheters were placed in the femoral artery and vein. Arterial blood was sampled and the ventilator adjusted to normalize blood gas values. In infused animals, a polyethylene (PE-10) catheter was placed in the external carotid artery and advanced to the carotid bifurcation. A ligature was placed around the catheter at the bifurcation to direct all infused solutions into the common carotid artery. Care was taken to avoid trauma to the carotid sinus, the carotid body, their nerves, and blood supplies. Saline, 0.9%, or ammonium acetate, 0.2 M, was infused via the catheter at 0.007 ml per minute with a Harvard pump (Harvard Apparatus Co., Inc., S. Natick, MA) and a 5 ml glass syringe. In half of the animals the electroencephalogram was monitored during the infusions. Arterial blood ammonia levels were measured by the method of Folbergrova et al. (13) .
Two normal and two portacaval shunt animals were fitted with external carotid artery catheters under halothane general anesthesia. After a 4-h recovery period, an ammonia infusion was started as described above. These alert, unrestrained animals were observed for the development of behavioral abnormalities (circling, seizures, coma, etc.) for 1 h. Gentle stimuli were applied to prevent sleep during the observation period.
To quantify the ammonia load imposed by the infusions, four additional normal animals were paralyzed, ventilated, and prepared with external carotid artery catheters, as described above. These animals were infused with cyclotron-produced '3N-labeled 0.2 M ammonium acetate (the specific activity of this solution changed rapidly due to the 10-min half-life of '3N while the ammonium acetate concentration remained 0.2 M). Details of the '3N-ammonia preparation have been published (9) . After a 10-min infusion, the animals were killed and the infused hemisphere was split into four portions in the coronal plane and isotope content was measured in a well counter. Appropriate corrections were made for isotope half-life.
Glucose metabolic rate measurement. . Regional glucose metabolic rate images were displayed with a Grinnel image-processing system using a pseudo-color scheme similar to that described by Goochee et al. (16) . Regions of interest on the metabolic images were identified with the aid of the thionin-stained sections and an atlas of rat brain anatomy ( 17) . Glucose metabolic rates were extracted and tabulated.
Statistical analyses. Differences in the glucose metabolic rate in specific brain nuclei from the infused vs. the noninfused side of the brain were sought using the paired t test. Preinfusion vs. postinfusion arterial ammonia concentrations were also compared with this test. Differences between mean metabolic rates observed in normal and portacaval shunt animals were determined with Student's t test.
Additional analyses of metabolic relationships were conducted using normalized regional metabolic values. Normalization was accomplished 1 . Abbreviations used in this paper: DG, 2-[2-'4C1-deoxy-D-glucose; rc, congruence coefficient.
by dividing the measured metabolic rate in each brain region of a given animal by the mean metabolic rate for all structures sampled in that animal. This eliminates variations that are attributable to the fact that some animals had metabolic rates that were uniformly high or low for all brain regions but has no effect on comparisons of the metabolic rate from one region in the animal to other regions for the same animal.
A principal component analysis among 20 regions in normal animals and 19 regions in portacaval shunt animals was conducted using the individual normalized values as described by Overall and Klett (18) . Two factors, arbitrarily labeled A and B, were extracted from both the normal and portacaval shunt groups. The congruence coefficient, r,, was computed to determine whether the extracted factors A and B in the normal animals were similar or different from the factors extracted from the portacaval shunt animals using procedures described by Cattel ( 19) . The brachium conjunctivum for portacaval animals was excluded from this analysis because of the relatively small size of that sample (n = 4).
The normalized values were used to compute a 20 by 20 correlation matrix to display the correlation between the metabolic rate in one region with the rate in all other sampled regions. For the sake of simplicity, only those correlation coefficients with P values less than or equal to 0.05 are included. A test for differences between individual correlation coefficients from the normal animals vs. the portacaval shunt animals was conducted as described by Bruning and Kintz (20) .
Results

Physiological effects ofammonia infusion
A total of 14 normal and 9 portacaval shunt animals were studied with the DG method. Arterial ammonia levels in eight normal animals averaged 0.088±62 mM (SD) and 0.296±0.122 mM in four portacaval shunt animals. Paired t tests showed that intracarotid ammonia and saline infusions did not alter the systemic arterial ammonia concentration. Physiological data are shown in Table I .
Alert, unrestrained, normal and portacaval shunt animals did not exhibit any behavioral abnormalities before or during the 1-h infusion ofammonium acetate at the specified rate. Large increases in the infusion rate produced facial twitching followed by generalized seizures in all animals, confirming proper catheter placement. About half of the animals that were paralyzed, ventilated, and infused with ammonia, developed slowing of the electroencephalogram that was observable over the infused hemisphere.
We based our ammonia infusion schedule on our desire to dissect any primary metabolic effects of ammonia on glucose metabolism from secondary effects due to epileptic seizures or coma. Assuming that the normal animals had a cerebral blood flow of0.9 ml * g-' * min-' (2) and a cerebral ammonia extraction of 45% (9) Fig. 1 , and ofportacaval shunt animals similarly infused in Fig. 2 . In anterior sections of normal animals infused with ammonium acetate, increases in glucose metabolism were seen in the anteromedial and medial nuclei of the thalamus. In more posterior sections, the ventral nucleus of the thalamus was activated along with hypothalamic nuclei. In sections containing the substantia nigra and the superior colliculus, activation was seen in these nuclei along with the red nucleus, the medial geniculate body, and posteriorly, in the reticular activating system around the aqueduct. The largest increases were observed in the substantia nigra. In the example shown in Fig. 1 , the nigral metabolic rate was 197 uM -100 g-* min-' in the infused side as compared with the mean control rate of 39±11 M 1 l00 g-' * min-' (+SD).
In portacaval shunt animals, the pattern of the additional increase in glucose metabolism associated with ammonium acetate infusion was similar to that observed in the normal animals, but less striking. The substantia nigra was less sensitive in this group in which maximal effects were produced in hypothalamic nuclei.
Discussion
Cerebral glucose metabolism during hyperammonemia or a portacaval shunt. Cirrhosis of the liver ranks sixth as a cause of lost years of life in the United States (21). During the terminal phases of the diseases that produce cirrhosis, repeated episodes of encephalopathy contribute to the morbidity and mortality of the condition. Convincing clinical and experimental evidence links hyperammonemia with the development of encephalopathy and coma (1) (2) (3) (4) (5) (6) (7) (8) . Ammonia-rich hepatic portal blood is shunted into the systemic circulation as a complication ofportal hypertension, or as the result of surgical procedures. The resulting hyperammonemia contributes to the development of brain dysfunction. This study was designed to evaluate the changes in brain glucose metabolism that occur after a portacaval shunt, to relate those changes to those observed after intracarotid infusions of ammonia to clarify the role of hyperammonemia in producing postshunt alterations in brain glucose metabolism, and to define potential mechanisms relevant to the development of portalsystemic or hyperammonemic encephalopathy. Although the brain is totally dependent on glucose as its energy source under normal conditions and metabolic rates in the brain are usually reduced during periods of encephalopathy, the data concerning brain glucose metabolism and the effects of hyperammonemia are confficting. James et al. (22) reported that whole-brain blood flow, oxygen and glucose consumption rose, then fell after portacaval shunt construction in dogs. In another publication, he reported that there was a lightening ofanesthesia in normal dogs after an ammonia infusion (23). Hawkins et al. (24) reported increases in cerebral glucose consumption after the induction of acute hyperammonemia in rats. Eklof et al. (25) reported a reduction in oxygen metabolism 2 wk after portacaval a shunt in rats, and Gjedde et al. (2) found increases in flow with normal oxygen metabolism 8 wk after portacaval shunt construction. However, in these same animals there were marked reductions in cerebral blood flow and oxygen metabolism after Tests for significant differences between correlation coefficients. Entries in this table are the probability values associated with a test of whether the indicated metabolic correlations were different in the two groups. For example, the first entry in the second column, 0.006, indicates that the correlation between the lateral cortex and the globus pallidus in the normal group (r = -0.568, see Table IV ) was different from that in the portacaval shunt group (r = 0.634, not included in table) at a level of significance equal to 0.006. an ammonia load, changes not observed 4 wk after portacaval shunting, indicating an increase in the sensitivity to the toxic effects of ammonia (2) . In studies of humans, Bianchi-Porro et al. (26) found increased blood flow in portacaval shunt patients who were neurologically normal, and Morgan et al. (27) reported low blood flow, glucose, and oxygen metabolic rates in encephalopathic patients with normalization after successful treatment, in substantial agreement with an earlier report by Posner and Plum (28) . In more recent papers, Mans et al. (29) reported reductions in regional glucose use 8 wk after portacaval shunting in rats whereas Cruz and Duffy (8) reported increases in glucose under experimental conditions that appear to be identical, with the exception of the method used to measure glucose use.
We measured the glucose metabolic rate in 20 brain regions and found significant increases in each region 8 wk after portacaval shunt construction. The increases were smallest in the cortex, ranging from 12 to 18% above the control value, were larger in the thalamic, hypothalamic and basal ganglionic regions, and were greatest in the reticular formation where glucose use was increased to 74% above the control value. These findings are in substantial agreement with those of Cruz and Duffy (8) . 8 wk after portacaval shunt construction they reported glucose use was increased in all but five ofthe 36 structures they surveyed. These increases reached statistical significance in 13 brain regions that in general were similar to the regions in which we observed maximal effects. We did not observe decreases in the glucose metabolic rates in portacaval animals as reported by Mans et al. (29) , or in animals (both normal and portacaval shunt) subjected to threshold ammonia infusions via the carotid artery.
Effects ofammonia on brain glucose metabolism. Since we desired to examine threshold metabolic events attributable to ammonia infusions, the amount of ammonia that was infused was not massive, as was the case in the studies of Hawkins et al. (24) , where brain ammonia levels increased from 0.2 to 1.53 mM. As might be expected, the results ofour glucose metabolism studies varied: not all animals showed a metabolic response to the infusion and the intensity of the response varied. These observations are consistent with the frequency with which electroencephalographic changes were seen, the variability in the '3N-ammonia infusion studies, which we believe to cause the variability of the ammonia response, and observations of unanesthetized, ammonia-infused animals. Visual inspection ofthe quantitative images of cerebral glucose consumption indicated that about half of the normal and half of the animals with portacaval shunts exhibited increases in glucose use in the infused hemisphere: unilateral decreases in the glucose metabolic rate were not observed. We conclude that in normal and portacaval shunt animals, brain glucose metabolism is increased by relatively small increments in the amount of ammonia delivered to the brain when infusion schedules are designed to avoid possible behavioral effects of ammonia. Individual brain regions vary in their susceptibility to this effect. Adding 0.05 AM of ammonia per gram of brain per minute appears to be the threshold for observing a metabolic effect. The occasionally dramatic nature ofammonia effect is shown in Fig. 1 , where the glucose metabolic rate in the substantia nigra of the infused hemisphere was more than three times greater than in the contralateral nigra. It seems likely that more severe hyperammonemia, especially in the portacaval shunt animals, would produce coma, as observed in earlier studies (2) , and that under these more extreme conditions glucose metabolism would be reduced.
In addition to hyperammonemia, portacaval shunts produce a variety of metabolic changes in both rats and humans, and many of these changes have been suggested as factors that produce encephalopathy. Alterations in the plasma branched chain/ aromatic amino acid ratio (30) and increases in gamma-amino butyric acid occur (31) and have been held to be etiologically responsible for the production of encephalopathy. We were reluctant to attribute the increases in brain glucose metabolism observed in the portacaval animals to hyperammonemia on the basis of a correlation analysis relating brain glucose metabolism in the two groups to the blood ammonia concentration, since any two variables that occur with predictable regularity after a shunt would almost certainly correlate at a statistically significant level, regardless of whether a cause-and-effect relationship existed. However, we believe that the results of the intracarotid infusion studies provide convincing evidence to link the observed changes in brain glucose metabolism with hyperammonemia. Not only did small amounts of exogenous ammonia increase brain glucose metabolism, but the increase occurred in a pattern that was very similar to the metabolic pattern observed after a portacaval shunt.
Since enzymes related to ammonia metabolism and neuropathological changes after hyperammonemia are confined to astrocytes, Norenberg (6) has argued that the nervous system dysfunction after hyperammonemia can be attributed to astrocytic abnormalities. The nuclear specificity observed in the present studies suggests that there may be a neuronal component as well. Since the metabolic response to hyperammonemia and portacaval shunting is not generalized but is specific to nuclei or nuclear groups, it is possible that brain regions differing in their cytoarchitectural characteristics differ in their response to exogenous ammonia. The actions of ammonia on the brain are complex: in addition to metabolic abnormalities already cited, the response includes changes in membrane electrical properties, thought to be attributable to chloride pump inhibition (32). Interactions between metabolic and physiological abnormalities in mixed glial and neuronal populations that use different neurotransmitters, such as those in the substantia nigra, may explain the nuclear specificity to exogenous ammonia.
Implications for the pathogenesis of hyperammonemic encephalopathy. The differences in regional susceptibility to the effects of ammonia implied by our data analysis suggest that portacaval shunting and hyperammonemia affect the metabolism, and presumably the function, of individual cerebral nuclei and fundamental patterns of cerebral interaction. These effects may be of importance in the development of the clinical signs and symptoms of hepatic encephalopathy.
The hypothesis that there are differences in regional cerebral interactions of normal vs. portacaval shunt animals is strengthened by an inspection of the results of the principal component analysis shown in Table III, the tabulated correlation coefficients  shown in Table IV , and the test for differences between correlation coefficients shown in Table V . The extracted factors (A, and B in Table III) describe major dimensions along which the measured regional metabolic rates covary. The congruence coefficients show that the factor loading values shown in the table are significantly dissimilar. Beyond this, objective criteria are not available to describe the results of this analysis, but inspection of the coefficients (magnitude and sign) and determining which of the two factors predominates for a given brain region (greatest absolute magnitude) provides insight into the degree of similarity between the post-shunt and normal metabolic relationships. Data from populations with identical interactions would yield identical coefficients for both extracted components. Inspection of the correlation coefficients from the principal component analysis reveals very few similarities, which suggests that there are fundamental differences in metabolic interactions after a portacaval shunt, as implied by the computed congruence coefficients. Similarly, the large number of significant differences in correlation coefficients shown in Table V supports our hypothesis that there is a difference between the "metabolic anatomy" of normal vs. portacaval shunted rats. The protean nature of the signs and symptoms of hepatic encephalopathy in humans, including altered levels of consciousness, impaired cognition, movement disorders, corticospinal tract dysfunction with a Babinski response, and occasional epileptic seizures may be the result of alterations in functional cerebral interactions implied by the analysis of glucose metabolic patterns.
The largest increase in the glucose metabolic rate after a portacaval shunt was observed in the reticular formation, the portion of the brain responsible for maintaining consciousness. The reticular formation has been identified by McCandless and Schenker (5) as being highly sensitive to ammonia, since ATP, phosphocreatine, and glucose levels were selectively decreased in the reticular formation of mice during the precoma period of acute ammonia intoxication (5) . Our data showing rapid glucose use by the reticular formation after a portacaval shunt are consistent with their concept of selective vulnerability of the reticular formation to ammonia, and imply a link between the effects of ammonia on the reticular formation and the pathogenesis of coma.
Weight loss and cachexia are commonly observed after a portacaval shunt in animals (2, 8, 12) and in terminal liver disease in humans. The link between the hypothalamus, feeding behavior, and weight gain or loss was established in classical studies reported by Brobeck and his associates (33) . Morgane expanded these studies, described a series of feeding behaviors that depend on the activity of neural elements in and around the hypothalamus and medial forebrain bundle, and suggested that hunger drive originating in the mediolateral hypothalamus is suppressed by stimulating ventromedial hypothalamic centers (34) . It is possible that the ammonia-induced neural activation we observed in the ventromedial hypothalamus (see Figs. 1 and 2 ) inhibits hunger mechanisms and leads to weight loss. An additional more direct link between hyperammonemia and feeding behavior was reported by Noda and Chikamori who observed reductions in food intake after ammonium chloride injections into the prepyriform cortex (35) . Thus, hyperammonemia may lead to reductions in food intake by direct or indirect actions on cerebral satiety control centers. Weight loss and cachexia would follow. Lockwood et al. (1) found that substantial amounts of ammonia are metabolized and detoxified by skeletal muscle. In patients with end-to-side portacaval shunts, skeletal muscle was the primary organ for ammonia detoxification (1) . Therefore, loss of muscle bulk could then make an individual more likely to develop hyperammonemia. This, combined with increasing ammonia sensitivity, may lead to the development of a selfperpetuating cycle of hyperammonemia, appetite suppression, loss of additional skeketal muscle bulk, a further reduction in the ammonia detoxification capacity, and hyperammonemia.
Portal systemic encephalopathy is a syndrome with multiple neurological manifestations. We believe that the results of the present study strengthen the hypothesis that ammonia is ofgreat importance in the development of this disorder via direct actions on specific nuclei, such as the ventromedial hypothalamus or the ascending reticular activating system, coupled with ammonia induced alterations in normal functional interactions in the brain as reflected by changes in the pattern ofcerebral glucose metabolism.
